Catalyst Pharmaceutical CPRX Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's other income (expense)?
- Catalyst Pharmaceutical (CPRX) reported other income (expense) of $11M in Q1 2026.
- How has Catalyst Pharmaceutical's other income (expense) changed year-over-year?
- Catalyst Pharmaceutical's other income (expense) increased by 38.9% year-over-year, from $7.92M to $11M.
- What is the long-term trend for Catalyst Pharmaceutical's other income (expense)?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's other income (expense) has grown at a 209.1% compound annual growth rate (CAGR), from $282K to $25.74M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.